The Catch-22 of appraisals on the quality of observational studies
To access this article, please choose from the options below
Conflict of interest: The division of Pharmacoepidemiology and Pharmacotherapy employing author R.H.H.G. has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private–public-funded Top Institute Pharma (www.tipharma.nl, includes cofunding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; STROBE, Strengthening the reporting of observational epidemiology; STARD, Standards for Reporting of Diagnostic Accuracy; PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.
PII: S0895-4356(10)00175-7
doi:10.1016/j.jclinepi.2010.04.013
© 2010 Elsevier Inc. All rights reserved.
